The 'unprecedented' plunge in prescription drug prices
When patents for drugs like Lipitor and Plavix expire over the next two years, prices will drop as generics flood the market
Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide:
Which drugs are scheduled to go generic?
Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Why is this happening all at once?
In the 1990s, pharmaceutical researchers were "wildly successful at creating pills that millions of people take every day for long-term conditions," says the Associated Press. The patents, which were filed while the drugs were still being developed, generally last for about 20 years before expiring, so many drugs that were created in the 1990s will probably be available as generics in the next few years.
Will this result in significantly lower drug prices?
Yes. Generics typically cost 20 to 80 percent less than brand-name drugs. That's a "godsend" for people with chronic conditions like arthritis, high cholesterol, diabetes, and other illnesses — especially if these people have no prescription coverage. Hospitals, nursing homes, and long-term-care facilities will also benefit, since "using lower-priced generics will save them some money." Overall, the use of generics "saved the U.S. health-care system more than $824 billion from 2000 through 2009," says National Journal.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
What about the impact on Big Pharma?
"The profit dollars that companies used to reinvest in innovation are no longer going to be coming," says pharma consultant Terry Hisey, as quoted by the Associated Press. That raises "long-term concerns about the industry's ability to bring new medicines to market." Drug companies have already started laying off employees, and more belt-tightening is expected to occur.
Sources: Associated Press (2), LA Times, National Journal
-
5 inflammatory cartoons on the L.A. wildfires
Cartoons Artists take on climate change denial, the blame game, and more
By The Week US Published
-
The problems with the current social care system
The Explainer The question of how to pay for adult social care is perhaps the greatest unresolved policy issue of our time
By The Week UK Published
-
Austria's new government: poised to join Putin's gang
Talking Point Opening for far-right Freedom Party would be a step towards 'the Putinisation of central Europe'
By The Week UK Published
-
Scientists want to create an AI virtual cell
Under the radar Generative AI could advance medical research
By Devika Rao, The Week US Published
-
Mirror bacteria could pose major health risks
Under the Radar The experimental research could have dangerous impacts
By Devika Rao, The Week US Published
-
Are pig-organ transplants becoming a reality?
The Explainer US woman has gene-edited pig-kidney transplant, and scientists hope experimental surgery could save thousands of lives
By Abby Wilson Published
-
2024: the year of distrust in science
In the Spotlight Science and politics do not seem to mix
By Devika Rao, The Week US Published
-
Dark energy data suggest Einstein was right
Speed Read Albert Einstein's 1915 theory of general relativity has been proven correct, according to data collected by the Dark Energy Spectroscopic Instrument
By Peter Weber, The Week US Published
-
How AI-generated images are threatening science
Under The Radar Publishers and specialists are struggling to keep up with the impact of new content
By Abby Wilson Published
-
Humans are near peak life expectancy, study finds
Speed Read Unless there is a transformative breakthrough in medical science, people on average will reach the age of 87
By Peter Weber, The Week US Published
-
Detailed map of fly's brain holds clues to human mind
Speed Read This remarkable fruit fly brain analysis will aid in future human brain research
By Peter Weber, The Week US Published